![](/wp-content/uploads/2022/02/Feb-3.2022-Blast-Cover.png)
$599
Lannett, Merck, Roche, and BD Q4 ‘21 and FY ’21 Earnings Updates
A series of cardiometabolic-related news items have been observed: Lannett (press release), Merck (press release; slides), Roche (press release; slides), and BD (press release; slides) hosted their respective Q4 ’21 earnings calls. Below, FENIX provides highlights and insights for the respective new items.